Transplant Conference

ASHI Virtual Events

ASHI 46th Virtual Global Annual Meeting
October 19-21, 2020

ASHI site ❯

Upcoming One Lambda Events at ASHI

Check back often for updates.



Pre-ASHI Symposium Case Study: LOCI Video Series

Calling all HLA researchers!

Submit your case study for an opportunity to present at our Pre-ASHI workshop on October 13 or October 15, 2020 as part of our new LOCI (Labs and Organizations Carving Innovation) video series.

We're looking for case studies that examine your latest research, solutions implemented in your lab, or experience using the latest technologies in the field of HLA, such as antibody testing with an extended panel or NGS genotyping with a faster and more efficient workflow. You can find more details in the Guidelines and Rules tab.

Send us your most interesting case study today and join us at ASHI to share your work with colleagues from around the world.

Submit your eligible Case Study Entry to: 1lambda-marcom@thermofisher.com

 

 


Join Our Mailing List
 

Want to be informed about product updates and upcoming workshops?

Sign-up

 

Or, enroll via text message:
Text HLANEWS to 22828 to get started.

 

New Concepts and Innovations in HLA

 

Simplify your workflow with the most efficient Next Generation Sequencing method.

The AllType™ FASTplex™ NGS assay combines the convenience of multiplex PCR with workflow simplicity by eliminating most of the pipetting, purification, and quantification steps required by traditional methods. By pooling amplicons into a single tube in the first hour, libraries can be prepared for sequencing with minimal hands-on time.

View product ❯

 

Define Your DSAs with Greater Confidence

LABScreen™ Single Antigen ExPlex now offers an extended HLA antibody panel in a single-well setup! Paired with the original LABScreen SABs, ExPlex provides cutting-edge capabilities with a total of 151 Class I and 119 Class II Common and Well-Documented alleles.

View product ❯

 

Supporting the Fight Against COVID-19 with New Diagnostic Solutions

The COVID-19 pandemic has made it increasingly difficult for transplant clinicians and HLA labs to meet the unique needs of their patients. As part of our mission to support the transplant community, we are announcing a trio of solutions to support research, pre-transplant screening, and post-transplant care during this challenging time.

 
LABScreen Multi

Avoid TRALI risk by screening for HLA and HNA antibodies

Fast and effective HLA and HNA antibody screening is critical for mitigating the risk of TRALI and improving the safety of convalescent plasma therapy for treating COVID-19. One Lambda’s LABScreen™ Multi solution offers the only FDA-cleared assay for the simultaneous detection of HLA and HNA specific antibodies.

Learn More ❯   Read White Paper ❯

 
LABScreen COVID Plus

Detect COVID-19 Antibodies for a More Complete Antibody Profile

Research has found that pathogen infections similar to COVID-19 can lead to the development of HLA antibodies. With multiple distinct antigens and fragments, the LABScreen™ COVID Plus assay is more specific than current assays and, in combination with HLA antibody detection, can help provide a more complete picture of the patient’s antibody profile.

Learn more ❯

 
Remote Sample Collection

Coordinate remote DSA sample collection for your patients

Unfortunately, many transplant patients are avoiding regularly scheduled visits to testing centers during the COVID-19 pandemic. One Lambda has been working on coordinating an at-home specimen collection service to be available to patients who prefer to continue monitoring the health of their transplanted organ without traveling to a blood collection site.

Request Information ❯